American International Group’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

American International Group’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,312	Closed	-$439K	–	3409
2021 Q1	$439K	Buy	7,312 +2,966	+68%	+$107K	﹤0.01%	1906
2020 Q4	$65K	Sell	4,346 -125	-3%	-$1.74K	﹤0.01%	2870
2020 Q3	$51K	Buy	+4,471	New	+$76.4K	﹤0.01%	2883

American International Group's PAND Position: Q2 2021 in Review

American International Group sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 7,312 shares — an estimated $439K sold.

American International Group first reported a position in PAND in Q3 2020 and held it in 3 quarters. The position peaked at $439K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

American International Group reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
American International Group sold 7,312 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $439K.
American International Group first reported a position in Pandion Therapeutics Inc. Common Stock in Q3 2020 and held it in 3 quarters.
American International Group's Pandion Therapeutics Inc. Common Stock position peaked at $439K in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.